CONVENIENCE BEYOND ONCE DAILY^1#

ASK YOUR SPECIALIST IF TIVICAY IS RIGHT FOR YOU
WELL TOLERATED¹

ASK YOUR SPECIALIST IF TIVICAY IS RIGHT FOR YOU
NO INTERACTIONS

with proton pump inhibitors such as omeprazole, birth control pills, asthma, erectile dysfunction, hepatitis C medicines, sleeping pills¹

ASK YOUR SPECIALIST IF TIVICAY IS RIGHT FOR YOU
SMALLEST FUNDED HIV TABLET^1,2 IN NEW ZEALAND

ASK YOUR SPECIALIST IF TIVICAY IS RIGHT FOR YOU
NO INTERACTIONS WITH RECREATIONAL DRUGS & ALCOHOL¹

ASK YOUR SPECIALIST IF TIVICAY IS RIGHT FOR YOU
TAKE WITH OR WITHOUT FOOD, AT ANY TIME OF THE DAY¹

ASK YOUR SPECIALIST IF TIVICAY IS RIGHT FOR YOU
CAN BE TAKEN IN COMBINATION WITH HIV MEDICINES KIVEXA^{^} OR TRUVADA^*1

ASK YOUR SPECIALIST IF TIVICAY IS RIGHT FOR YOU

LEARN MORE

#PositiveStoriesNZ

Here three people living with HIV in New Zealand tell us their story.

LEARN MORE

What is HIV?

HIV stands for human immunodeficiency virus. It is a type of virus called a retrovirus.

It can be passed from person to person.

LEARN MORE

New Zealand Patient Support Groups

In this section you will find information about Patient Support Groups active in our country.

LEARN MORE

Can HIV be treated?

Although HIV can’t be cured, it can be treated. Modern HIV treatment means that many people with HIV are living long, healthy lives. People who are diagnosed in good time nowadays, and who receive the right treatment and care, are likely to have the same life expectancy as someone without HIV.¹

LEARN MORE

New Zealand Consumer Medicine Information Tivicay

For patient information about Tivicay, please refer to the consumer information leaflet (CMI) available on the Medsafe website.

# sometimes Tivicay must be taken twice a day; talk to your doctor if this applies to you

^ (lamivudine/abacavir)

* tenofovir/emtricitabine for full Consumer Medicine Information please refer to www.medsafe.govt.nz

References:

1. Tivicay (dolutegravir) Consumer Medicine Information GSK New Zealand November 2018

2. PHARMAC Pharmaceutical Schedule November; pharmac.govt.nz/schedule. Accessed 28 November 2018

3. Rodger AJ, Lodwick R, Schechter M, et al. Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population. AIDS. 2013;27(6):973-979.

TIVICAY (dolutegravir sodium), 50 mg film-coated tablets, is a Prescription Medicine that works as an integrase inhibitor, used for the treatment of Human Immunodeficiency Virus (HIV) infection in combination with other anti HIV agents in adults and children over 12 years of age and weighing 40kg or more. TIVICAY has risk and benefits and should only be prescribed by a doctor experienced in treating HIV. Ask your Doctor if TIVICAY is right for you. Use strictly as directed. If you have concerns or if you have side effects, see your doctor, pharmacist or healthcare professional. TIVICAY is a funded medicine; Special Authority criteria apply. Normal doctor’s consultation fees apply. You can view full Consumer Medicine Information at www.medsafe.govt.nz. TIVICAY and KIVEXA are registered trade mark of the ViiV Healthcare group of companies, marketed on behalf of ViiV Healthcare by GlaxoSmithKline NZ Limited, Auckland. Adverse events involving ViiV Healthcare products should be reported to ViiV Healthcare Medical Information on 0800 808 500.

For information regarding GSK products or to report an adverse event, please call Medical Information on 0800 808 500.

TAPS DA1921MB/19FEB/HIV/0001/16(1)a

Last update February 2019